EP3823632
EFDA IN COMBINATION WITH DORAVIRINE FOR USE IN TREATING F227C MUTATED HIV INFECTIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.7.2019EP published:
29.10.2025EP application number:
19837129.6
EPO information:
European Patent Register
Max expiry date:
11.7.2039
Title in English:
EFDA IN COMBINATION WITH DORAVIRINE FOR USE IN TREATING F227C MUTATED HIV INFECTIONSLanguage of the patent:
English
Timeline
Today
12.7.2019EP application
29.10.2025EP Publication
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
HAZUDA, Daria JeanAddress:
West Point, Pennsylvania 19486, US
Name:
LAI, Ming-TainAddress:
Lansdale, Pennsylvania 19446, US
Priority
Number:
201862699047 PDate:
17.7.2018Country:
US
Classification
Categories:
A61K 31/7076, A61P 31/18, A61K 45/06, A61K 31/4439